Tilray Brands, Inc. (TLRY) Stock Slides as Market Rises: Facts to Know Before You Trade

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $0.74, moving -6.34% from the previous trading session. This change lagged the S&P 500's daily gain of 0.78%. At the same time, the Dow added 1.14%, and the tech-heavy Nasdaq gained 0.61%. The company's shares have seen an increase of 105.84% over the last month, surpassing the Medical sector's loss of 0.02% and the S&P 500's gain of 5.88%.The investment community will be closely monitoring the performance of Tilray Brands, Inc. in its forthcoming earnings report. The company is scheduled to release its earnings on July 28, 2025. The company's earnings per share (EPS) are projected to be -$0.03, reflecting a 25% increase from the same quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $240.05 million, up 4.42% from the year-ago period. For the full year, the Zacks Consensus Estimates project earnings of -$1.01 per share and a revenue of $838.75 million, demonstrating changes of -206.06% and 0%, respectively, from the preceding year. Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Tilray Brands, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability. Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Tilray Brands, Inc. is currently sporting a Zacks Rank of #3 (Hold). The Medical - Products industry is part of the Medical sector. With its current Zacks Industry Rank of 175, this industry ranks in the bottom 30% of all industries, numbering over 250. The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions. 5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tilray Brands, Inc. (TLRY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks